Navigation Links
Labopharm Announces FDA Approval of Once-Daily RYZOLT(TM) (Tramadol HCL Extended Release Tablets) for Management of Moderate to Moderately Severe Chronic Pain
Date:12/31/2008

Product to be Launched in the U.S. in the Second Quarter of 2009

LAVAL, QC, Dec. 31 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that RYZOLT(TM) (tramadol HCl extended release tablets), Labopharm's once-daily formulation of the analgesic tramadol, has been approved by the U.S. Food and Drug Administration (FDA). RYZOLT is indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time.

"The approval of our first product in the United States is a major milestone for our Company and we look forward to our product's launch in the world's largest market for pain medications," said James R. Howard-Tripp, President and Chief Executive Officer, Labopharm Inc. "We believe that RYZOLT offers physicians and patients an excellent option for the treatment of pain with the benefit of once-daily dosing. We look forward to the launch of our product by our marketing partner for the U.S., Purdue Pharma."

RYZOLT is a centrally acting analgesic composed of a dual-matrix delivery system with both immediate-release and extended-release characteristics. Labopharm's marketing partner for its product in the United States, Purdue Pharma L.P., anticipates launching RYZOLT tablets in 100 mg, 200 mg and 300 mg dosage strengths in the second quarter of 2009.

The approval of RYZOLT is the first U.S. FDA approval that Labopharm has obtained for a medication using its patented Contramid(R) controlled-release technology for oral administration of solid dosage medications. Labopharm believes that its Contramid technology can be applied to a wide range of complex, small, highly water soluble molecules to control their release over a 24-hour period with a desired pharmacokinetic profile.

Pain is a potentially debi
'/>"/>

SOURCE Labopharm Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
2. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
3. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
4. Labopharm appeals FDAs decision on once-daily tramadol
5. Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
6. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
7. Labopharm Reports Results for Third Quarter Fiscal 2007
8. Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
9. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
10. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
11. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)... Julian Whitaker, MD, a founder of...d expert on searchjointpain.com, a new information...scle conditions and solutions. , ... Whitaker, MD, a founder of the alternative health...pain.com, a new informational Web site devoted to ...
(Date:7/2/2009)...sts at Singapore,s Bioprocessing Technology Instit...e gene, "Fas-apoptosis inhibitory molecule" (FAIM)...sis, or programmed cell death. , Their research...nd Differentiation . , The scientists, Jianxin H...that this process may possibly be manipulated for ...
(Date:7/2/2009)...MYERS, Fla., July 2 Ace...-counter and prescription medicines to help reliev...taminophen by a brand name, Tylenol and prescripti...dvisory committee for the FDA met on June 30, 2009...of acetaminophen. The committee voted 20-17 to ur...
(Date:7/2/2009)... Health one of 63 businesses honored in Washington...e-USNewswire/ -- Texas Health Resources has rece...ward from the National Business Group on Health. ,...h/20090702/DC41773LOGO ) , , The award recog...tive programs that promote a healthy workplace and...
Breaking Medicine News(10 mins):Health News:Dr. Julian Whitaker Featured on Searchjointpain.com 2Health News:Gene's novel role may provide key to treating liver and neurodegenerative diseases 2Health News:Viles & Beckman, LLC: Stop Your Headache NOT Your Liver 2Health News:Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 2Health News:Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 3
...d by Dr. Michael Brent, an associate professor of ...t. Louis, gives us an insight into the way childre...age.These findings were presented at the annual me...ancement of science in San Francisco.For years the...
... of the world, San Francisco is now reeling under ...tion. In the past one-year the rate of infection h...ct high-risk pockets of gay men, who are also intr...higher. And what is the cause for this sudden spur...
...lled the TAT vaccine has been developed in Italy a.... And more importantly it has had a 71% success ra...dy for human testing and this may be the brightest...e HIV. Dr.Barbara Ensoli, Head of the Department o...
...d patients, apart from suffering the social neglec...ve this major handicap - they just can’t travel li...ver they want. Some people just avoid having HIV i...t. Leaving the ethical issues aside, it is very di...
Other Medicine News:
(Date:7/2/2009)...OODCLIFF LAKE, N.J., July 2 Eisai ...O: Haruo Naito, "Eisai") and Eisai Corporation of ...hairman and CEO Hajime Shimizu) are currently focu...e company,s major product Aricept(R) (donepezil hy...ents with Alzheimer,s disease. As progress in thos...
(Date:6/30/2009)...June 30 Accumetrics, Inc. announce...ents) in the enrollment of its landmark clinical t... V erifyNow(R) Assay I mpact on T hrombosis A n...o demonstrate the value of providing clinicians wi...r responders to clopidogrel (Plavix(R)). The mult...
(Date:6/29/2009)...Minn., June 29 Pioneer...eness of deep brain stimulation (DBS) in hard-... (OCD) and Tourette,s syndrome are underway at mul...to a review in the June 2009 issue of Mayo Cl...ong been seen as valuable for controlling movement...
(Date:6/28/2009)...DE DO CORONADO, Portugal, June 29 ...hat add-on treatment with the novel,once-daily a...; ESL) resulted,in a marked and sustained decreas... Results from the one-year extension of a pivo...presented at the International Congress for Epilep...
Breaking Medicine Technology:Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value 2Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value 3Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled 2Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases 2Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 2Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 4Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 5Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 6Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 7Message to Tucson Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 18175 1Message to Tucson Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 18175 2Message to Tucson Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 18175 3Message to Tucson Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 18175 4Cardica Intuitive Surgical MAQUET Cardiovascular and Transonic to Host Innovations in Revascularization Symposium 18171 1Cardica Intuitive Surgical MAQUET Cardiovascular and Transonic to Host Innovations in Revascularization Symposium 18171 2Cardica Intuitive Surgical MAQUET Cardiovascular and Transonic to Host Innovations in Revascularization Symposium 18171 3Cardica Intuitive Surgical MAQUET Cardiovascular and Transonic to Host Innovations in Revascularization Symposium 18171 4Lilly Oncology to Unveil More Than 50 Studies at ASCO 2008 18167 1Lilly Oncology to Unveil More Than 50 Studies at ASCO 2008 18167 2Baxa Announces Colorado BioScience Association Sponsorship 5033 1Baxa Announces Colorado BioScience Association Sponsorship 5033 2Baxa Announces Colorado BioScience Association Sponsorship 5033 3
...eveloper Antisoma plc,(LSE: ASM, US OTC: ATSMY) to...ASA404 in recurrent, platinum-sensitive ovarian ca...4 plus chemotherapy,(n=37) with patients receiving...as follows: , * There was no advantage in median t...ed with the control arm * One-year survival,rates ...
...1, 2007 - The Journal of the,American Society of C...f a clinical study conducted by Dr. Siu-Fun Wong, ...al gel, Regenecare(R),caused a statistically sign...h that results from the use of anti-cancer drugs,k...are trial is,listed on the National Cancer Institu...
Other Medicine Technology:Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial 2Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial 3Clinical Study Shows Regenecare Relieves Pain and Itching of Skin,Rashes Caused by Widely Used Cancer Drugs 2
...f stainless steel with the proven antibacterial pr...ed copper-alloy-stainless interior that is sterile...nvironment promotes the integrity of samples, vali... This exclusive SANYO copper stainless steel alloy...
ArcticTemp Upright Freezer -20C. Quick, even freezing. Heavy duty compressor. Deep door racks. Front gated bottom shelf. Interior light. Locks One year warranty on unit and 5 year warranty on compres
...ine pH, mV (ORP), relative mV and temperature meas...e obtained when used with a temperature probe (ATC..., two- and three-point calibration with Auto-Find ...1.68, 4.00, 7.00, 10.01 and 12.45) and Auto-Read f...
...of system for pH, mV (ORP), relative mV, concentra...re compensated pH results can be obtained when use...rode. Up to five custom buffers are supported. &bu...32 interface to connect to a printer or a computer...
Medicine Products: